Findings of pulmonary amyloidosis on dual phase FDG PET/CT imaging

Clinical Nuclear Medicine

Volumn 35, Issue 3, 2010, Pages 206-207

  Tan, Haibo ^a   Guan, Yihui ^a   Zhao, Jun ^a   Lin, Xiangtong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Dual phase imaging; FDG, PET CT; Pulmonary amyloidosis

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AMYLOIDOSIS; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LUNG AMYLOIDOSIS; LUNG BIOPSY; LUNG LESION; LUNG TUMOR; POSITRON EMISSION TOMOGRAPHY;

AMYLOIDOSIS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG DISEASES; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77649150825     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3181cc64b5     Document Type: Article

References (15)

1. Husby G. Nomenclature and classification of amyloid and amyloidoses. J Intern Med. 1992;232:511-512.
2. Monroe AT, Walia R, Zlotecki RA, et al. Tracheobronchial amyloidosis: a case report of successful treatment with external beam radiation therapy. Chest. 2004;125:784-789.
3. Ollenberger GP, Knight S, Tauro AJ. False-positive FDG positron emission tomography in pulmonary amyloidosis. Clin Nucl Med. 2004;29:657-658.
4. Grubstein A, Shitrit D, Sapir EE, et al. Pulmonary amyloidosis: detection with PET-CT. Clin Nucl Med. 2005;30:420-421.
5. Arena V, Skanjeti A, Casoni R, et al. Dual-phase FDG-PET: delayed acquisition improves hepatic detectability of pathological uptake. Radiol Med. 2008;113:875-886.
6. Shinya T, Rai K, Okumura Y, et al. Dual-time-point F-18 FDG PET/CT for evaluation of intrathoracic lymph nodes in patients with non-small cell lung cancer. Clin Nucl Med. 2009;34:216-221.
7. Xiu Y, Bhutani C, Dhurairaj T, et al. Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity. Clin Nucl Med. 2007;32:101-105.
8. Zhuang H, Pourdehnad M, Lambright ES, et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med. 2001;42:1412-1417.
9. Penna D, Varetto T, Deandreis D, et al. Dual-phase F-18 FDG PET/CT scanning in the suspicion of relapse of ovarian neoplasia. Clin Nucl Med. 2009;34:111-113.
10. Ahmadzadehfar H, Sabet A, Nake K, et al. Dual-time F-18 FDG-PET/CT imaging for diagnosis of occult non-Hodgkin lymphoma in a patient with esophageal cancer. Clin Nucl Med. 2009;34:168-170.
11. Zytoon AA, Murakami K, El-Kholy MR, et al. Positron emission tomography and breast lesions: low FDG activity in early phase imaging is not essentially benign. Clin Nucl Med. 2008;33:931-933.
12. Tian R, Su M, Tian Y, et al. Dual-time point PET/CT with F-18 FDG for the differentiation of malignant and benign bone lesions. Skeletal Radiol. 2009; 38:451-458.
13. Nishiyama Y, Yamamoto Y, Fukunaga K, et al. Dual-time-point 18F-FDG PET for the evaluation of gallbladder carcinoma. J Nucl Med. 2006;47:633-638.
14. Lan XL, Zhang YX, Wu ZJ, et al. The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions. Clin Radiol. 2008;63:756-764.
15. Kumar R, Loving VA, Chauhan A, et al. Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET. J Nucl Med. 2005;46:1819-1824.